Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The field of depression therapy has seen its biggest leap forward in over three decades, the FDA approval of Janssen’s CIII nasal spray Spravato (...
Akcea Therapeutics and Ionis Pharmaceuticals have announced that their investigational therapy Waylivra has been recommended by the EMA’s CHMP for...
AbbVie’s interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has secured recommendation from the EMA’s Committee for Medicinal Products for...
As part of an effort to promote low cost medicines the Indian government has announced plans to colour code generic drugs.
Canadian physicians have called on the federal government to review its funding for a programme which sends volunteer homeopaths to Honduras.
Biogen has announced it has inked an agreement to acquire clinical-stage gene therapy firm Nightstar for a total value of $800 million, which...
The head of NHS England has warned that ‘vaccination deniers’ are increasing their influence on social media through ’fake news’.
British scientist develops technology able to deliver drugs directly into the brain More than 40% of GPs intend to quit within five years Rise in...
The news kicked off 2009 with a bang when Bristol-Myers Squibb announced it intended to acquire Celgene for $74 billion, but what could potentially...
Among the swirling storm emanating from the testimony of Donald Trump’s ex-lawyer Michael Cohen to the House Oversight Committee, one of the many...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches